home / stock / wint / wint news


WINT News and Press, Windtree Therapeutics Inc. From 03/31/22

Stock Information

Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Website: windtreetx.com

Menu

WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...

WINT - Windtree to Participate in the Lytham Partners Spring 2022 Investor Conference

WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, President and Chief Executive Officer...

WINT - Windtree TherapeuticS GAAP EPS of -$2.73 misses by $0.17

Windtree TherapeuticS press release (NASDAQ:WINT): FY GAAP EPS of -$2.73 misses by $0.17. As of December 31, 2021, the Company reported cash and cash equivalents of $22.3 million. For further details see: Windtree TherapeuticS GAAP EPS of -$2.73 misses by $0.17

WINT - Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the fourth quarter and year...

WINT - Windtree Announces Results from Its Phase 2 Study of Lucinactant for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) and Lung Injury

WARRINGTON, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced results from its Phase 2 study of lucinactant (K...

WINT - CENN, GLOP and BPT among pre market gainers

United Time Technology (UTME) +46%. BT Brands (BTBD) +37%. O2Micro International (OIIM) +31%. Anaplan (PLAN) +28% Thoma Bravo agrees to buy Anaplan for $10.7B.  Vinco Ventures (BBIG) +22%. Marine Petroleum (MARPS) +21%. Mullen Automotive (MULN) +20%. Cuentas (CUEN) +14% pa...

WINT - Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock

WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its ...

WINT - Windtree to Present at Oppenheimer's 32nd Annual Healthcare Conference

WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, President ...

WINT - MARPS, DAVE and HYPR among mid-day movers

Gainers: Dave (NASDAQ:DAVE) +37%. Windtree Therapeutics (NASDAQ:WINT) +24%. BioRestorative Therapies (NASDAQ:BRTX) +19%. Creative Realities (NASDAQ:CREX) +19%. Biofrontera (NASDAQ:BFRI) +18%. voxeljet (NASDAQ:VJET) +18%. Immunic (NASDAQ:IMUX) +18%. Digihost Technology (NASDAQ:DGHI) +17%. Hype...

WINT - Windtree completes enrollment in phase 2 trial of lucinactant for COVID-19 lung injury

Windtree Therapeutics (WINT) completed enrollment in its phase 2 study of lucinactant (KL4 surfactant) for patients with COVID-19 associated lung injury and acute respiratory distress syndrome (ARDS). Data is expected in Q1. The trial enrolled 20 patients to evaluate the safety and tolerabili...

WINT - RIDE, RKLB and CLLS among pre market gainers

AMC Entertainment Holdings (NYSE:AMC) +14% as preliminary Q4 revenue tops consensus. Wallbox (NYSE:WBX) +14% Uber and Wallbox to expand partnership to all of the U.S. Spire Global (NYSE:SPIR) +10% as preliminary Q4 revenue soars 111% Y/Y. ObsEva (NASDAQ:OBSV) +9%. ProQR Th...

Previous 10 Next 10